BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6514088)

  • 1. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal drug exposure: effects on neonatal and infant growth and development.
    Chasnoff IJ; Burns KA; Burns WJ; Schnoll SH
    Neurobehav Toxicol Teratol; 1986; 8(4):357-62. PubMed ID: 3762846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydrug- and methadone-addicted newborns: a continuum of impairment?
    Chasnoff IJ; Hatcher R; Burns WJ
    Pediatrics; 1982 Aug; 70(2):210-3. PubMed ID: 7099786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine/polydrug use in pregnancy: two-year follow-up.
    Chasnoff IJ; Griffith DR; Freier C; Murray J
    Pediatrics; 1992 Feb; 89(2):284-9. PubMed ID: 1370867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal narcotic exposure: perinatal and developmental effects.
    Kaltenbach KA; Finnegan LP
    Neurotoxicology; 1989; 10(3):597-604. PubMed ID: 2696902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual evoked potentials in infants exposed to methadone in utero.
    McGlone L; Mactier H; Hamilton R; Bradnam MS; Boulton R; Borland W; Hepburn M; McCulloch DL
    Arch Dis Child; 2008 Sep; 93(9):784-6. PubMed ID: 18305073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
    Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
    Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal methadone exposure: effects on behavior in early infancy.
    Johnson HL; Rosen TS
    Pediatr Pharmacol (New York); 1982; 2(2):113-20. PubMed ID: 12760403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal alcohol exposure and infant behavior: immediate effects and implications for later development.
    Coles CD; Smith IE; Falek A
    Adv Alcohol Subst Abuse; 1987; 6(4):87-104. PubMed ID: 3425480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The infants of adolescent mothers.
    Merritt TA; Lawrence RA; Naeye RL
    Pediatr Ann; 1980 Mar; 9(3):100-10. PubMed ID: 7360510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of maternal opiate abuse on the newborn.
    Finnegan LP
    Fed Proc; 1985 Apr; 44(7):2314-7. PubMed ID: 3884386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1984; 6(4):271-5. PubMed ID: 6392916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal addiction: a two-year study. Part I. Clinical and developmental characteristics of infants of mothers on methadone maintenance.
    Ramer CM; Lodge A
    Addict Dis; 1975; 2(1-2):227-34. PubMed ID: 1163366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting head growth and intellectual function in children of drug addicts.
    Lifschitz MH; Wilson GS; Smith EO; Desmond MM
    Pediatrics; 1985 Feb; 75(2):269-74. PubMed ID: 3969327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.